Newborn screening for inborn errors of metabolism (IEMs) is an essential public health initiative that facilitates early detection of genetic disorders affecting metabolic pathways. By utilising ...

A committee of experts will conduct a study examining the current landscape of newborn screening (NBS) systems, processes, and research in the United States and consider sustainable adoption of ...

Newborn screening (NBS) as a public heath endeavor faces a complex array of needs, competing priorities, and viewpoints. NBS programs, federal agency partners, families, care providers, and many ...

Workflow of combined biomarker and genetic newborn screening. This schematic illustrates the integrated framework for neonatal combined screening, linking disease and gene selection with standardized ...

Newborn screening (NBS) is a public health service available to approximately 3.6 million infants born in the United States each year. Over 98 percent of those infants receive screening. State and ...